Document Detail

Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
MedLine Citation:
PMID:  2328299     Owner:  NLM     Status:  MEDLINE    
The influence of food on the bioavailability of a conventional tablet and of a slow-release capsule of diltiazem was investigated in two separate groups of 24 healthy volunteers in two open crossover studies. Diltiazem, as a conventional tablet (2 x 30 mg, first group) or as a slow-release capsule (120 mg SR, second group), was administered in a fasting condition and 30 min after a breakfast of 784 kcal (23 per cent proteins, 55 per cent lipids, and 22 per cent of carbohydrates). Multiple blood samples were withdrawn during the next 24 h and diltiazem, desmethyldiltiazem, and deacetyldiltiazem were assayed by HPLC. Neither the rate of absorption, assessed by the rate constant of absorption, the peak plasma concentration, and the time required to reach the peak, nor the amount of drug reaching the systemic circulation, assessed by the area under the plasma concentration time curve (AUC infinity) were influenced by food, and that independently of the formulation. Compared to the fasting experiment, food did not affect either the rate of formation or the AUC infinity of desmethyldiltiazem or deacetyldiltiazem. The results of the present study show that the relative bioavailability of the single dose of diltiazem administered as a slow-release capsule is significantly higher (69 per cent) than that estimated after the administration of diltiazem in a conventional tablet. It was concluded that food does not influence the bioavailability of diltiazem administered as a conventional tablet or as a slow-release formulation.
P Du Souich; N Lery; L Lery; F Varin; S Boucher; M Vezina; D Pilon; J Spenard; G Caillé
Related Documents :
520399 - Food-induced reduction in bioavailability of atenolol.
18607579 - Effect of food on systemic exposure to niflumic acid following postprandial administrat...
6528959 - A pharmacokinetic study of the recommended dosing schedules of theo-dur and uniphylline.
19630979 - Arterial roads and area socioeconomic status are predictors of fast food restaurant den...
8345569 - Oral absorption and bioavailability of fenbendazole in the dog and the effect of concur...
11361049 - The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor gw420867...
17665189 - Understanding nonaflatoxigenicity of aspergillus sojae: a windfall of aflatoxin biosynt...
17229899 - Treating irritable bowel syndrome with a food elimination diet followed by food challen...
9844309 - Toxic effects of acute inhalation exposure to 1,2,4,5-tetramethylbenzene (durene) in ex...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Biopharmaceutics & drug disposition     Volume:  11     ISSN:  0142-2782     ISO Abbreviation:  Biopharm Drug Dispos     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-05-30     Completed Date:  1990-05-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7911226     Medline TA:  Biopharm Drug Dispos     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  137-47     Citation Subset:  IM    
Département de Pharmacologie, Faculté de Médecine, Université de Montréal, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Biological Availability
Delayed-Action Preparations
Diltiazem / administration & dosage,  analogs & derivatives,  blood,  metabolism,  pharmacokinetics*
Drug Administration Schedule
Middle Aged
Reg. No./Substance:
0/Delayed-Action Preparations; 42399-40-6/deacetyldiltiazem; 42399-41-7/Diltiazem; 85100-17-0/N-monodemethyldiltiazem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man.
Next Document:  Pharmacokinetic analysis of absorption and metabolism of dopamine and a dopamine prodrug in dogs.